Functional characterization of high levels of meningioma 1 as collaborating oncogene in acute leukemia
- 14 January 2010
- journal article
- Published by Springer Science and Business Media LLC in Leukemia
- Vol. 24 (3), 601-612
- https://doi.org/10.1038/leu.2009.272
Abstract
Retroviral expression of leukemogenic oncogenes in the murine hematopoietic system is essential but not sufficient to induce acute leukemia. Proviral integration-mediated elevated expression of the meningioma 1 (MN1) oncogene suggested MN1 acting as cooperating event in mixed-lineage leukemia 1 (MLL) and eleven nineteen leukemia (ENL)-induced murine leukemia. Indeed, co-expression of MN1 with MLL-ENL enhanced transformation in vivo, and resulted in a significantly reduced latency for induction of an aggressive acute leukemia when compared with MN1 or MLL-ENL alone. In addition, co-expression of MN1 increased the granulocyte macrophage progenitor cell population with leukemia-initiating properties as shown in secondary transplantation experiments. Gene expression profiling experiments identified putative downstream MN1 targets, of which FMS-like tyrosine kinase 3 (FLT3) and CD34 were upregulated in both MN1-overexpressing murine leukemias and in pediatric acute leukemias with high MN1 levels. Interestingly, small interfering RNA (siRNA)-mediated MN1 knockdown resulted in cell cycle arrest and impaired clonogenic growth of human leukemia cell lines with high MN1 levels. Our work shows for the first time that high MN1 levels are important for the growth of leukemic cells, and that increased MN1 expression can synergize with MLL-ENL and probably other transforming fusion genes in leukemia induction through a distinct gene expression program that is able to expand the leukemia-initiating cell population.Keywords
This publication has 36 references indexed in Scilit:
- Prognostic Importance of MN1 Transcript Levels, and Biologic Insights From MN1-Associated Gene and MicroRNA Expression Signatures in Cytogenetically Normal Acute Myeloid Leukemia: A Cancer and Leukemia Group B StudyJournal of Clinical Oncology, 2009
- Acute myeloid leukemia induced by MLL-ENL is cured by oncogene ablation despite acquisition of complex genetic abnormalitiesBlood, 2009
- Significance of heat-shock protein (HSP) 90 expression in acute myeloid leukemia cellsCell Stress and Chaperones, 2008
- Malignant Transformation Initiated by Mll-AF9: Gene Dosage and Critical Target CellsCancer Cell, 2008
- Meis1 is an essential and rate-limiting regulator of MLL leukemia stem cell potentialGenes & Development, 2007
- Candidate Genes for Expansion and Transformation of Hematopoietic Stem Cells by NUP98-HOX Fusion GenesPLOS ONE, 2007
- MN1, a novel player in human AMLBlood Cells, Molecules, and Diseases, 2007
- Retroviral Insertional Mutagenesis Identifies Genes that Collaborate with NUP98-HOXD13 during Leukemic TransformationCancer Research, 2007
- ReSETting PP2A tumour suppressor activity in blast crisis and imatinib-resistant chronic myelogenous leukaemiaBritish Journal of Cancer, 2006
- Transformation from committed progenitor to leukaemia stem cell initiated by MLL–AF9Nature, 2006